CBG is a non-intoxicating cannabinoid, which means it does not produce the narcotic effect typical of THC.

Since it is found in small amounts (usually less than 1%) in most hemp varieties, CBG is considered a low cannabinoid. Surprisingly CBG is a building block for other cannabinoids - especially for THC and CBD. To achieve higher profits, CBG breeders are experimenting with genetic engineering and plant crossbreeding.

Researchers can also extract higher levels of CBG from plants by determining the optimal extraction time, approximately six weeks in eight weeks of the flowering cycle.

The built-in endocannabinoid (ECS) system of the human body works to keep the body in a balanced state of homeostasis. Although there are specific details about how cannabinoids work, the endocannabinoid system generally performs various functions specific to each area of the body.

For example, the endocannabinoid system at the wound site (bruise) can help to regulate immune cells to reduce inflammation. It has been found that CBG affects very specific physiological systems, and the problems and results for medical use are promising. Endocannabinoid receptors dominate in eye structures, and interestingly, CBG is particularly effective in the treatment of glaucoma because it reduces intraocular pressure. It is a potent vasodilator and has neuroprotective effects.

The researchers are excited about these initial results from CBG and will support future research only with CBG alone or CBG in combination with other cannabinoids and multiple diseases. Since it is non-psychotropic, CBG has a promising wide range of potential applications not only for the above-mentioned problems but also as an analgesic, psoriasis therapy and as an antidepressant.

CBG, or cannabigerol, is an often-overlooked cannabinoid, although it is extremely important. In fact, it is the needed source for causing most of the effects of hemp. It acts as a precursor to CBD, THC and some other cannabinoids. As the plant grows, CBG is converted to other cannabinoids by enzymes in the plant, so it tends to be present in low levels when the hemp is ready for harvest.

Cannabigerol (CBG) is not psychoactive and is known to block metabolic activity, the psychoactive effects of THC. CBG has been shown to stimulate neurogenesis (brain cell growth). CBG is also antibacterial, anticancer and helps in insomnia.